Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Fastfwd Innov LSE:FFWD London Ordinary Share GG00BRK9BQ81 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25p -2.08% 11.75p 11.50p 12.00p 12.00p 11.75p 12.00p 412,989 14:02:29
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.0 3.8 2.9 4.1 19.61

Fastfwd Innov Share Discussion Threads

Showing 9426 to 9449 of 9450 messages
Chat Pages: 378  377  376  375  374  373  372  371  370  369  368  367  Older
DateSubjectAuthorDiscuss
15/1/2019
23:01
The rise continues UP 5.26% today on volume of 1.5 Million. News has finally arrived on one investment showing a significant gain on our investment. I hope the news will start to come regularly now so we can get back to a much higher share price.
888icb
15/1/2019
22:59
I sold a good position from 9.5p. Still have a 100k left.
ayesha4
15/1/2019
19:09
Thanks Kristin I, there was a 80000 trade at 11.83,ithought you got lucky at that price, but it must have been someone else. Good buy on your part nevertheless, gl.
thelogman
15/1/2019
15:55
13-13.5p Way higher than 9p lows but miles lower than 30p highs Do I buy or wait for a shake
dave4545
15/1/2019
15:54
Great stuff! A few more smiling faces with this one but the inevitable leak with shares moving strongly ahead before this was announced. FastForward Innovations Limited Juvenescence Series B Funding 15/01/2019 3:45pm UK Regulatory (RNS & others) Fastfwd Innov (LSE:FFWD) Intraday Stock Chart Today : Tuesday 15 January 2019 Click Here for more Fastfwd Innov Charts. TIDMFFWD RNS Number : 1754N FastForward Innovations Limited 15 January 2019 15 January 2019 FastForward Innovations Ltd ("FastForward" or the "Company") Juvenescence Limited completes first tranche of Series B Funding Secures investment of US$46 million The Board of AIM-traded FastForward Innovations Limited, trading under the symbol FFWD, ("FastForward", the "Company" or "FFWD"), is pleased to announce that investee company Juvenescence Limited ("Juvenescence") has completed the first tranche of its planned US$100-125 million funding round. In aggregate Juvenescence has closed on subscriptions from new and existing investors to raise US$46 million at a price of US$24.70 per share. The price of the Series B funding round values Juvenescence at a price of US$400 million and is at a 58 per cent. premium to the price at which the Company invested in the Juvenescence Series A funding round in June 2018 (see 19 June 2018 announcement). At the price per share of the Series B funding round, the Company's holding of 128,205 shares of Juvenescence have an implied value of approximately US$3.2 million, representing an increase of approximately US$1.2 million from the Company's Series A investment. Commenting on the close of the Series B funding round Lorne Abony, FastForward's Chief Executive Officer, noted: "We are delighted with the progress Juvenescence is making with the pipeline of drugs, therapies and technologies they are developing. Having spent time with the company's management in the past few weeks in San Francisco I share their optimism in relation to near-term potential of the company. The successful initial public offer of Age-X Therapeutics Inc. (NYSE:AGE), in which Juvenescence has a 46% interest, is a great example of the expertise Juvenescence brings to drug development companies. The reaction of the investor community to the AgeX listing demonstrates the potential for the longevity industry, in North America and, we hope, in Europe. We look forward to updating shareholders in due course with further positive news from the Juvenescence portfolio of assets." About Juvenescence Juvenescence Limited is a biotech company focused on therapies to increase healthy human longevity. It was founded in 2017 by Jim Mellon, Dr. Greg Bailey, Dr. Declan Doogan, Anthony Chow, and Alexander Pickett. The Juvenescence team are highly experienced drug developers, and serial entrepreneurs with a track record of success in life sciences and drug development. Juvenescence is focused on developing therapeutics that alter ageing or age-related diseases. Juvenescence believes that recent advances in science have greatly improved our understanding of the biology of ageing and creates the opportunity to develop therapeutics now that can slow, halt or potentially reverse elements of ageing. The Juvenescence founders and management team have an extensive track record of successfully developing drugs for a range of diseases. Further details regarding Juvenescence are available at its website www.juvenescence.ltd
niggle
15/1/2019
10:15
pleased to see a bit of renewed interest.
hazl
15/1/2019
08:44
i think the order was worked at 12.25 p, will check.... so at 13.46 ; 80000 ; 0.1225 for £9800 settlement
kristini2
14/1/2019
22:02
Another positive day UP 9.2%. FFWD starting to show long awaited signs of life in anticipation of some major news.It would be good to see it back to at least the 15p Placing price before news lands.
888icb
14/1/2019
18:21
What price did you get Kristin I, if you Don,t mind me asking.
thelogman
14/1/2019
18:18
Which cretin voted my post down, obviously not invested here. Well done Kristin I nice buy.
thelogman
14/1/2019
17:42
added another 80000 shares today.... just seen the contract note, Go ffwd !! should averaged down at 9.5p.... but the past two day price action looks promising !
kristini2
14/1/2019
17:08
News this week Ricky by the looks of it. Volume is the key here and it is picking up and new investors coming in now. Think more will follow anticipating the start of the news flow.
thelogman
14/1/2019
11:44
Be a good time for some news.
rickyl1
14/1/2019
11:25
Good to see this rise continuing currently UP 12.5% on volume of 500000.
888icb
14/1/2019
11:16
nice move and on small volumes....
kristini2
14/1/2019
10:06
Some nice share price movement at last. Could be the news stacking up. Leaks ?
rickyl1
14/1/2019
00:52
A 12.7% rise on Friday which I hope will be continued this week. There is so much pending news on several investments each of which should be potentially massive in their own right. It is difficult to comprehend why the share price is not a lot higher.
888icb
11/1/2019
06:55
Yeah looking that way jonesyboy. Let the news from a truly amazing pf begin.
thelogman
10/1/2019
22:45
Looking likely we are getting back into cannabis via Emmac, which looks stunning with the team they have created.
jonesyboy 27
10/1/2019
20:04
Never in all my years of investing/trading have I been more confident of making big gains here at these silly prices. Lorne, s pal buying over a million pounds worth at over 17p,leap sale anytime now, intensity in meeting with everyone it seems, factom, well what can one say about that.... It gonna be huge. Yooya, the slightly unknown, could be enormous to us on ipo. Juve another massive upside on ipo. We are not drilling for oil, just waiting for the inevitable big rise 8n share price
thelogman
08/1/2019
23:24
I really like the look of Vemo even though it’s only showing as £276k. On the balance sheet. I’m sure we will soon see a masssive increase in value even to the point it is valued way in excess of our original investment of around £1m. It’s often overlooked but could give quite a result.
brave dave
08/1/2019
22:01
https://twitter.com/greenhamneggs/status/1082758024110985217?s=21 Click and read the tweet and the presentation attached. Looks like the cannabis investment to me
jonesyboy 27
06/1/2019
21:25
Just read in the Sunday Times in an article on a company in video gaming that the industry is worth £79 Billion per annum and will be bigger than music and cinema combined by 2021. On e new game Red dead redemption 2 took £560 million on its first weekend. This shows the potential for Leap Gaming.
888icb
06/1/2019
19:35
The half year report issued on 12 Dec valued our assets as at 30Sept 2018. Our 2 investments in Factom were together valued at £5.1 Million. I don’t know what percentage holding this relates to. Our original investment of US$400000 related to 3.64% according to the note above. We have since committed by convertible loan an additional US$6 Million. There is a link on LSE to an article on blockchain Companies. Factom is the first one mentioned and is valued at US$500 Million. So 1% of Factom is worth US$5 Million(£3.9 Million)which if we will have 5% that would be £19.5 Million. Does any know the likely percentage? Whatever it is the future looks very bright.
888icb
Chat Pages: 378  377  376  375  374  373  372  371  370  369  368  367  Older
Your Recent History
LSE
FFWD
Fastfwd In..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190117 19:06:17